| Provincial House Of Adrian | |
| 700 Lakeshire Tr, Adrian, Michigan 49221 | |
| (517) 263-0781 | |
| Name | Provincial House Of Adrian |
|---|---|
| Location | 700 Lakeshire Tr, Adrian, Michigan |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 117 |
| Occupancy Rate | 52.65% |
| Medicare ID (CCN) | 235287 |
| Legal Business Name | Lenawee Long Term Care |
| Ownership Type | Non Profit - Corporation |
| NPI Number | 1548223720 |
| Organization Name | LENAWEE LONG TERM CARE |
| Doing Business As | PROMEDICA SKILLED NURSING AND REHABILITATION (ADRIAN) |
| Address | 700 Lakeshire Trl, Adrian, MI 49221 |
| Phone Number | 517-263-0781 |
News Archive
"Around the world, frontline health workers are often the first link to lifesaving care and supplies, and in some cases they are the only link for families and communities in rural and impoverished areas," Oying Rimon, a senior program officer in family health at the foundation, writes in this post in the Bill & Melinda Gates Foundation's "Impatient Optimists" blog.
Elixir Medical Corporation, a developer of products that combine state-of-the-art medical devices with advanced pharmaceuticals, announced today that it has received approval from the Food and Drug Administration to initiate patient enrollment in the EXCELLA III clinical trial in the United States at up to 50 institutions with conditions to be addressed in parallel.
Celera Corporation and its collaborators at the University of California at San Francisco today announced the publication of a paper confirming the association of an increased risk of coronary heart disease (CHD) and two variants of the LPA gene. The two LPA single nucleotide polymorphisms (SNPs) are Ile4399Met, a polymorphism in the protease-like domain of LPA, and rs10455872, a SNP located in a non-coding region of the LPA gene.
An ultra-low-molecular-weight heparin called semuloparin has been found to reduce the incidence of venous thromboembolism in orthopedic surgery patients in a large clinical program being lead by a steering committee chaired by McMaster University professor Dr. Alexander Turpie.
› Verified 5 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
"Around the world, frontline health workers are often the first link to lifesaving care and supplies, and in some cases they are the only link for families and communities in rural and impoverished areas," Oying Rimon, a senior program officer in family health at the foundation, writes in this post in the Bill & Melinda Gates Foundation's "Impatient Optimists" blog.
Elixir Medical Corporation, a developer of products that combine state-of-the-art medical devices with advanced pharmaceuticals, announced today that it has received approval from the Food and Drug Administration to initiate patient enrollment in the EXCELLA III clinical trial in the United States at up to 50 institutions with conditions to be addressed in parallel.
Celera Corporation and its collaborators at the University of California at San Francisco today announced the publication of a paper confirming the association of an increased risk of coronary heart disease (CHD) and two variants of the LPA gene. The two LPA single nucleotide polymorphisms (SNPs) are Ile4399Met, a polymorphism in the protease-like domain of LPA, and rs10455872, a SNP located in a non-coding region of the LPA gene.
An ultra-low-molecular-weight heparin called semuloparin has been found to reduce the incidence of venous thromboembolism in orthopedic surgery patients in a large clinical program being lead by a steering committee chaired by McMaster University professor Dr. Alexander Turpie.
› Verified 5 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 3 |
| Total Amount of Fines in Dollars | $37656 |
| Number of Payment Denials | 1 |
| Total Number of Penalties | 4 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 13.99 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 8.46 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 47.17 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 0.9 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 3.39 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 1.79 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 4.13 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 100 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 7.42 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 85.84 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 2.78 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 20.52 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 26.44 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 5.65 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 99.68 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 76.73 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 73.26 | 82.93 |
News Archive
"Around the world, frontline health workers are often the first link to lifesaving care and supplies, and in some cases they are the only link for families and communities in rural and impoverished areas," Oying Rimon, a senior program officer in family health at the foundation, writes in this post in the Bill & Melinda Gates Foundation's "Impatient Optimists" blog.
Elixir Medical Corporation, a developer of products that combine state-of-the-art medical devices with advanced pharmaceuticals, announced today that it has received approval from the Food and Drug Administration to initiate patient enrollment in the EXCELLA III clinical trial in the United States at up to 50 institutions with conditions to be addressed in parallel.
Celera Corporation and its collaborators at the University of California at San Francisco today announced the publication of a paper confirming the association of an increased risk of coronary heart disease (CHD) and two variants of the LPA gene. The two LPA single nucleotide polymorphisms (SNPs) are Ile4399Met, a polymorphism in the protease-like domain of LPA, and rs10455872, a SNP located in a non-coding region of the LPA gene.
An ultra-low-molecular-weight heparin called semuloparin has been found to reduce the incidence of venous thromboembolism in orthopedic surgery patients in a large clinical program being lead by a steering committee chaired by McMaster University professor Dr. Alexander Turpie.
› Verified 5 days ago
Lenawee Medical Care Facility Location: 200 Sand Creek Hwy, Adrian, Michigan 49221 Phone: (517) 263-6794 | |
The Oasis At Adrian Rehabilitation And Nursing Ctr Location: 130 Sand Creek Hwy, Adrian, Michigan 49221 Phone: (517) 265-6554 |